Smad3 Conditional Knockout mouse models

Lacking the exon 3 insert that keeps SMAD2 off DNA, the protein encoded by Smad3 (human SMAD3) binds CAGAC SMAD-binding elements directly through its MH1 domain after ALK5 phosphorylates its carboxy-terminal SSVS motif, then trimerizes with SMAD4 and cooperates with AP-1, TCF and FOXO factors to drive collagen, Serpine1 and Foxp3 transcription. This direct DNA engagement makes it the dominant effector for TGF beta driven fibrosis, epithelial to mesenchymal transition and induced regulatory T cell generation. Human loss-of-function mutations cause aneurysm-osteoarthritis syndrome, a Loeys-Dietz variant, providing a knockin rationale distinct from deletion. Constitutive nulls are viable with immune dysregulation, colorectal tumors and protection from experimental fibrosis, so conditional alleles are needed chiefly to separate stromal, epithelial and T cell compartments. Given that Smad2 and Smad3 diverge in DNA binding rather than receptor use, allele selection should follow whether the endpoint is transcriptional output or receptor-proximal signaling.

Conditional deletion of Smad3 limits the genetic change to the lineage you choose. That helps in oncology, immunology, and metabolic work where systemic loss would muddy the read. After you confirm Cre specificity, crossing to Smad3 floxed stock yields usable cohorts.